1. Home
  2. ALLR vs BOXL Comparison

ALLR vs BOXL Comparison

Compare ALLR & BOXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • BOXL
  • Stock Information
  • Founded
  • ALLR 2004
  • BOXL 1985
  • Country
  • ALLR United States
  • BOXL United States
  • Employees
  • ALLR N/A
  • BOXL N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • BOXL Telecommunications Equipment
  • Sector
  • ALLR Health Care
  • BOXL Telecommunications
  • Exchange
  • ALLR Nasdaq
  • BOXL Nasdaq
  • Market Cap
  • ALLR 15.8M
  • BOXL 4.9M
  • IPO Year
  • ALLR N/A
  • BOXL 2017
  • Fundamental
  • Price
  • ALLR $0.94
  • BOXL $1.79
  • Analyst Decision
  • ALLR Strong Buy
  • BOXL Buy
  • Analyst Count
  • ALLR 1
  • BOXL 3
  • Target Price
  • ALLR $9.00
  • BOXL $5.00
  • AVG Volume (30 Days)
  • ALLR 367.8K
  • BOXL 22.4K
  • Earning Date
  • ALLR 08-15-2025
  • BOXL 08-13-2025
  • Dividend Yield
  • ALLR N/A
  • BOXL N/A
  • EPS Growth
  • ALLR N/A
  • BOXL N/A
  • EPS
  • ALLR N/A
  • BOXL N/A
  • Revenue
  • ALLR N/A
  • BOXL $113,560,000.00
  • Revenue This Year
  • ALLR N/A
  • BOXL N/A
  • Revenue Next Year
  • ALLR N/A
  • BOXL N/A
  • P/E Ratio
  • ALLR N/A
  • BOXL N/A
  • Revenue Growth
  • ALLR N/A
  • BOXL N/A
  • 52 Week Low
  • ALLR $0.61
  • BOXL $1.06
  • 52 Week High
  • ALLR $6.00
  • BOXL $10.65
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 47.03
  • BOXL 41.24
  • Support Level
  • ALLR $0.85
  • BOXL $1.70
  • Resistance Level
  • ALLR $1.01
  • BOXL $2.43
  • Average True Range (ATR)
  • ALLR 0.05
  • BOXL 0.16
  • MACD
  • ALLR -0.01
  • BOXL -0.04
  • Stochastic Oscillator
  • ALLR 47.55
  • BOXL 25.58

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.

Share on Social Networks: